Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Assessments of nursing home guidelines for quality of care provided to residents with multiple sclerosis.
Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice.
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
Yoga effects on physical activity and sexual satisfaction among the Iranian women with multiple sclerosis: a randomized controlled trial.
Microglia and astrocyte activation in the frontal cortex of rats with experimental autoimmune encephalomyelitis.
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
Coping and its importance for quality of life in patients with multiple sclerosis.
Multiple sclerosis: Reprogramming the immune repertoire with alemtuzumab in MS.
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.
Multiple sclerosis: potential risk factors in childhood and adolescence.
Reliability and Repeatability of the Hoffmann Sign.
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis.
Multiple perspectives on the health service need, use, and variability among older adults with multiple sclerosis.
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
Multiple sclerosis: Worrying data on excess mortality and comorbidity in MS.
Interaction Study of Phospholipid Membranes with an N-Glucosylated β-Turn Peptide Structure Detecting Autoantibodies Biomarkers of Multiple Sclerosis.
Vascular malformation mimicking multiple sclerosis active plaque: Usefulness of susceptibility weighted imaging (SWI) to perform correct diagnosis.
Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
Editorial: Fatigue in Multiple Sclerosis.
Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling.
Pages
« first
‹ previous
…
695
696
697
698
699
700
701
702
703
…
next ›
last »